CARING FOR PATIENTS WITH MESOTHELIOMA: PRINCIPLES AND GUIDELINES

1. History of Pleural Surgical Treatment
2. History Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Metastasis and Evolution and Contemporary Application in Peritoneal Mesothelioma
3. Cytoreductive Surgery and Intraperitoneal Chemotherapy for Treatment of Malignant Peritoneal Mesothelioma
4. Radiation Therapy
5. Chemotherapy and Standard Treatment Options
6. Caring for Patients During and After Immunotherapy Treatment
7. Biotherapy Treatment: Mesothelin-Targeted Therapies
8. Care of the Mesothelioma Patient Undergoing Extended Pleurectomy and Decortication
9. Maintaining a Nutritional Diet During and After Active Treatment
10. Mesothelioma and Physical Therapy
11. Occupational Therapy and Mesothelioma
12. Respiratory Therapy and Pulmonary Rehabilitation for Mesothelioma Patients
13. Palliative Care Services for Mesothelioma Patients
14. Difficult Conversations and Survivorship
15. End-of-Life Care
16. Public Health Impact of Asbestos Worldwide: What Is the Current Public Health Impact?
17. Understanding Clinical Trials in Malignant Mesothelioma
18. The Future of Mesothelioma Research: Basic Science Research
19. The Impact of the Internet on Mesothelioma Patients: The Good, the Bad, and the Ugly
20. Patient Perspective on Mesothelioma Treatment

This book encompasses all areas for mesothelioma care, treatment, and research. Using nurses, social workers, surgeons, oncologist, radiologist and pain specialist to give the reader a comprehensive overview of mesothelioma treatment. Indeed, mesothelioma is a cancer that mainly affects the pleura and peritoneum, usually caused by exposure to asbestos. The number of individuals diagnosed with mesothelioma is increasing world-wide, particularly in developing countries where the use of asbestos remains uncontrolled. In spite of advances in chemotherapy, radiotherapy, and surgical approaches, mesothelioma remains resistant to treatment. According to the International Mesothelioma Interest group, overall survival has not improved; median survival times vary from one month to eighteen months. A small number of patients remain asymptomatic or with minimal symptoms for extended periods, and fewer live three years or more. Mesothelioma is often associated with difficult, intractable symptoms, particularly pain and difficulty breathing. Especially poor prognoses have been reported for those diagnosed with sarcomatoid rather than epithelioid histology, or with advanced disease, poor performance status, or pain and loss of appetite. Despite substantial progress of the last two decades improving the quality of life of patients with cancer, many mesothelioma patients still experience physical, psychological, social, and financial burdens. The development of multimodality treatment and mesothelioma centers has given renewed hope to patients. This book serves as a unique tool for medical professional while providing care for mesothelioma patients.

Features
• Offers the first focus on Long term care and survivorship regarding mesothelioma patients
• Highlight the development of multimodality treatment allowing for more effective and targeted treatment
• Encompasses all areas for mesothelioma care, treatment, and research